GT Biopharma Inc Up 20.52% To $0.56 After Earnings Miss

GT Biopharma Inc (GTBP) missed earnings projections on 3/30/2023 for Q4 2022.Analyst expectations for GT Biopharma Inc earnings per share (EPS) were at a loss of $0.17 per share, with the company missing those estimates with a reported EPS loss of $0.18 per share, leading to a negative surprise of $0.01 per share (-6%). GT